| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2022 | Mar 2021 | Mar 2019 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 139.29M | 136.63M | 136.17M | 162.02M | 120.85M | 94.11M |
| Gross Profit | 37.89M | 41.43M | 40.88M | 55.17M | 36.00M | 30.71M |
| EBITDA | 17.04M | -6.56M | -3.69M | -55.99M | 9.19M | 8.75M |
| Net Income | 3.28M | -22.85M | -17.86M | -69.86M | 698.00K | 877.00K |
Balance Sheet | ||||||
| Total Assets | 185.52M | 180.95M | 209.97M | 226.52M | 275.14M | 207.41M |
| Cash, Cash Equivalents and Short-Term Investments | 17.20M | 17.42M | 27.43M | 26.59M | 42.05M | 37.24M |
| Total Debt | 58.15M | 59.98M | 64.54M | 70.66M | 69.21M | 62.43M |
| Total Liabilities | 89.24M | 83.63M | 91.16M | 104.02M | 102.27M | 80.27M |
| Stockholders Equity | 96.28M | 97.32M | 118.81M | 122.50M | 137.34M | 92.69M |
Cash Flow | ||||||
| Free Cash Flow | 4.75M | 8.83M | 3.72M | -13.04M | -42.34M | -19.66M |
| Operating Cash Flow | 8.51M | 10.72M | 7.20M | 16.73M | 2.27M | 2.38M |
| Investing Cash Flow | -11.76M | -16.63M | -8.40M | -59.27M | -48.89M | -22.57M |
| Financing Cash Flow | -5.86M | -3.97M | 1.74M | 25.55M | 38.74M | 48.61M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | £1.14B | 16.42 | 15.06% | 0.74% | 23.97% | 216.41% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
57 Neutral | £216.52M | -0.48 | -29.91% | ― | -5.85% | -413.36% | |
56 Neutral | £148.93M | -34.00 | 3.39% | ― | 1.45% | ― | |
55 Neutral | £3.73B | 28.33 | 1.69% | 6.76% | 3.30% | -58.67% | |
54 Neutral | £986.56M | 18.78 | 4.75% | 5.97% | -4.27% | -28.32% |